Your session is about to expire
← Back to Search
Outpatient Cervical Ripening for Pregnancy
Study Summary
This trial looks at whether starting the induction process at an outpatient clinic is more effective and safer for patients.
Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I currently have an active genital herpes infection.I am scheduled for labor induction due to conditions like diabetes or high blood pressure.My placenta covers my cervix and/or is abnormally attached to my uterus.I have experienced vaginal bleeding without a known cause.I have had surgery on my uterus before.I have a heart condition as a mother.
- Group 1: Outpatient Cervical Ripening
- Group 2: Inpatient Cervical Ripening
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Are there still opportunities for participants in this clinical investigation?
"Per information found on clinicaltrials.gov, this research is not presently recruiting patients. This project was initially posted April 1st 2012 and underwent the most recent modification May 23rd 2012. Although enrollment has closed at this moment, there are 79 other studies actively requiring volunteers."
Who has the qualifications to join this investigative endeavor?
"This trial seeks 800 expectant mothers aged 18-60 who meet the additional requirements of term pregnancy and scheduled induction for labor (due to conditions such as gestational diabetes or chronic hypertension)."
Is the current research effort open to elderly applicants?
"This medical trial only enrolls participants between 18 and 60. For those that are younger than 18 or older than 65, there are separate clinical trials available; 21 for the former group and 34 for the latter cohort."
Share this study with friends
Copy Link
Messenger